Introduction
Virulence associated with several Gram-negative bacterial pathogens requires the translocation of "effector" proteins from bacteria into host cells through a dedicated protein translocation apparatus termed the type III secretion system (TTSS) (Galan and Collmer, 1999; Cornelis and Van Gijsegem, 2000) . Many bacterial effector proteins possess a specialized activity required to limit anti-microbial immune response and promote bacterial growth and dissemination during pathogenesis. We are particularly interested in the mechanisms of type III effector proteins found in the attaching and effacing (A/E) pathogen group including enteropathogenic Escherichia coli (EPEC) and its close relatives, enterohaemorrhagic Escherichia coli (EHEC 0157:H7) and Citrobacter rodentium that cause severe gastrointestinal disease. Although the coordinated actions of several type III effector proteins including Tir, Map, EspF, EspG, EspH, EspI, EspJ, EspK, EspZ, and NleA-F are required for virulence associated with A/E pathogens, the biochemical activities of most effectors are poorly defi ned.
Microbial pathogens may hijack the actin cytoskeleton machinery to perform a variety of functions that include actinbased motility, cellular invasion, and intracellular traffi cking through the endocytic pathway (Gruenheid and Finlay, 2003) . A key regulator of the actin cytoskeleton is neuronal WiskottAldrich syndrome protein (N-WASP), a eukaryotic protein that initiates actin fi lament branching and assembly through the direct activation of the Arp2/3 complex. Due to its critical role in this process, N-WASP is tightly regulated by upstream signals including phospholipids (PIP 2 ), the small G-protein Cdc42,
The type III effector EspF coordinates membrane traffi cking by the spatiotemporal activation of two eukaryotic signaling pathways B acterial toxins and effector proteins hijack eukaryotic enzymes that are spatially localized and display rapid signaling kinetics. However, the molecular mechanisms by which virulence factors engage highly dynamic substrates in the host cell environment are poorly understood. Here, we demonstrate that the enteropathogenic Escherichia coli (EPEC) type III effector protein EspF nucleates a multiprotein signaling complex composed of eukaryotic sorting nexin 9 (SNX9) and neuronal WiskottAldrich syndrome protein (N-WASP). We demonstrate that a specifi c and high affi nity association between EspF and SNX9 induces membrane remodeling in host cells. These membrane-remodeling events are directly coupled to N-WASP/Arp2/3-mediated actin nucleation. In addition to providing a biochemical mechanism of EspF function, we fi nd that EspF dynamically localizes to membranetraffi cking organelles in a spatiotemporal pattern that correlates with SNX9 and N-WASP activity in living cells. Thus, our fi ndings suggest that the EspF-dependent assembly of SNX9 and N-WASP represents a novel form of signaling mimicry used to promote EPEC pathogenesis and gastrointestinal disease.
and Src homology-3 (SH3) adaptor proteins (Higgs and Pollard, 2001) . Recent work also indicates that N-WASP is intimately associated with mechanisms of endocytosis (Merrifi eld et al., 2004; Benesch et al., 2005; Kaksonen et al., 2006) , a cellular process required for the uptake of extracellular components including microbial pathogens and viruses (Veiga and Cossart, 2006) .
Membrane remodeling during endocytosis requires the spatiotemporal coordination of several phospholipids and F-actin binding proteins (Merrifi eld et al., 2002; Kaksonen et al., 2005) . As a specifi c example, sorting nexin 9 (SNX9) is dynamically recruited to clathrin-coated pits (CCPs) at the late stages of vesicle formation (Lundmark and Carlsson, 2003; Soulet et al., 2005) . Although the exact role of SNX9 is not well understood, its domain architecture suggests that it links the plasma membrane to proteins associated with the cellular cortex. SNX9 possesses two lipid interaction domains, a phospholipid-binding module termed the phox (PX) domain followed by a putative Bin/Amphiphysin/Rvs (BAR) lipid-binding domain. Interestingly, the BAR domain is a banana-shaped helical dimer that senses membrane curvature and can reconfi gure lipid vesicles or sheets into membrane tubules (Peter et al., 2004) . In addition to its lipid-binding properties, SNX9 also possesses an N-terminal Src homology-3 (SH3) protein interaction module that was recently shown to bind WASP (Badour et al., 2007) and to functionally activate dynamin at CCPs (Soulet et al., 2005) . Thus, SNX9 is uniquely suited to regulate the membrane/cytoskeletal interface during clathrin-mediated endocytosis.
In this paper, we found that the type III effector EspF coordinates membrane remodeling and F-actin polymerization during EPEC pathogenesis. Similar to previous results (Marches et al., 2006) , we found that EspF binds the SH3 domain of SNX9 and we further demonstrated that this interaction induces membrane remodeling, a phenotype that is functionally coupled to N-WASP-dependent actin polymerization in eukaryotic cells. EspF activated both SNX9 and N-WASP in a coordinated spatiotemporal pattern at CCPs. Importantly, these data provide a molecular mechanism for EspF function in host cells and further suggest that the dynamic interplay between bacterial type III effector proteins and eukaryotic signaling pathways is a critical aspect of host-pathogen interactions.
Results

Identifi cation of SNX9 and N-WASP as an EspF-binding protein
Database searches reveal that EspF orthologues are found in an A/E pathogen group that includes EPEC, EHEC 0157:H7, and Citrobacter rodentium (Fig. 1, A and B) . EspF is composed of 47 amino acid proline-rich repeats (PRRs) that are repeated several times throughout the coding sequence. Although the repeat numbers vary amongst EspF orthologues in A/E pathogens, there are no cases where the PRR sequence is present as a single copy. In addition, EHEC 0157:H7 possesses a second PRR domain protein called EspFu/TccP that shares 35% homology with EspF, but has a distinct biological function (Campellone et al., 2004; Garmendia et al., 2004) . To defi ne eukaryotic binding partners we screened EspF against a mouse embryo cDNA library using the yeast two-hybrid system. Screening of 8 million yeast transformants yielded fi ve positives. Two cDNAs encoded the SH3 domain of SNX9 (Fig. 1 C, residues 1-111 ) and the Cdc42/rac interactive binding (CRIB) domain of N-WASP (Fig. 1 D, residues 200-258 ).
EspF binds SNX9 through a highly evolved
SH3 ligand motif
Our yeast two-hybrid clone spanned residues 1-111 of SNX9, a region encompassing its SH3 domain. This interaction was confi rmed using [
35 S]-methionine labeled SNX9 1-111 (SH3 domain) and recombinant GST-EspF fusion protein, which selectively interacted in pull-down assays (Fig. 2 A) . Grb2, Nck1, and Nck2, three SH3 domain-containing proteins with broad ligand specifi city, could not be copurifi ed with EspF (Fig. 2 A) . Similar binding specifi city was also observed in vivo by coimmunoprecipitation assays from transfected Hek293A cells.
These data demonstrate that EspF interacts with full-length SNX9 but not Grb2, Nck1, or Nck2 in cells (Fig. 2 B) .
In general the ‫003ف‬ SH3 domains in the human genome bind ligands with a canonical PxxP motif. It was surprising that only one SH3 protein was identifi ed in our high coverage yeast two-hybrid screen. To better understand this apparent specifi city, we used phage-displayed peptide libraries to explore the binding specifi city profi les of the SH3 domain of SNX9. The SH3 domain was screened against a library composed of 10 10 completely random dodecapeptides. After four rounds of affi nity selection, 150 individual binding-phage were sequenced. Remarkably, only 13 unique peptides were identifi ed from the 150 sequences, suggesting that SNX9 recognizes a highly conserved sequence motif (Fig. 2 C) . Homology alignment was used to derive a SNX9 specifi city profi le in the form of a preferred binding motif (Fig. 2 C) . Notably, the specifi city profi le confi rmed that the SH3 domain recognizes multiple features of the ligand sequence; an arginine was invariant at the −3 position, alanine was preferred at the −1, and prolines were selected at the 0 and +3 positions of the PxxP motif. These data determine the preferred consensus SNX9 SH3 ligand motif as RxAPxxP.
Next, an in vitro-translated 35 S-SNX9 was used to screen a solid phase library containing peptides of 15-mer residues (offset every three residues) spanning amino acids 1-166 in EspF (Fig. 2 D) . By overlaying 35 S-SNX9 onto the EspF peptide library, we found that the SH3 binding site in EspF was confi ned to two distinct regions within residues 75-81 and 122-128 (Fig. 2 D) . Remarkably, these regions in EspF both possess a common RxAPxxP motif that conforms to the SNX9 SH3 consensusbinding motif identifi ed in our unbiased phage display. Because residues 75-81 and 122-128 are found at the N-terminal portion of PRR domain 1 and 2, respectively, and because homologous regions are found in all EspF orthologues, we can conclude that each PRR domain of EspF possesses a single SNX9 binding site (see the alignment in Fig. 1 ). In support of this conclusion, a dissociation constant of 2.2 μM was experimentally derived from an EspF peptide (RPAPPPP) bound to the SNX9-SH3 domain (Fig. 2 E) , suggesting that these residues constitute the minimal sequence required for SNX9 interaction. In addition, we substituted aspartic acids for the arginines in position 75, 122, and 169 (Arg 75, 122, 169 →Asp or EspF-D3) in all three PRR domains of EPEC EspF. Mutant EspF-D3 failed to bind SNX9 in both in vitro pull-down assays (unpublished data) and coimmunoprecipitation experiments (Fig. 2 F) .
EspF induces Arp2/3-dependent actin assembly through the direct activation of N-WASP Next, we turned to the interaction between EspF and N-WASP. Full-length N-WASP interacted with EspF in coimmunoprecipitation assays, but not with control EGFP (Fig. 3 A) . This interaction was comparable to the interaction between N-WASP and prophage-expressed EspFU/TccP gene that displays 35% identity to EspF (Fig. 1 B) (Garmendia et al., 2006) . These data suggest that the functionally distinct EspF and EspFU/TccP proteins both interact with N-WASP in eukaryotic cells.
We tested the ability of EspF to directly activate N-WASP by assaying Arp2/3 complex-dependent actin polymerization kinetics using a pyrene-actin assembly assay in vitro. For these assays, we used Arp2/3-complex purifi ed from bovine brain extracts and purifi ed N-WASP ∆EVH1 (residues 138-501), an N-WASP truncation mutant lacking the WH1/EVH1 domain that exhibits strong autoinhibition (Fig. 3 B) (Co et al., 2007) . In addition, a purifi ed 6×-His tagged EspF protein possessing three intact PRR domains was used in these studies (EspF∆47, (Fig. 3 B) . In the absence of either N-WASP or the Arp2/3 complex, EspF did not alter F-actin assembly dynamics (Fig. 3 C) . However, in the presence of both Arp2/3 and N-WASP ∆EVH1, EspF stimulated actin nucleation (Fig. 3 C) . These data indicate that EspF directly activates N-WASP in vitro.
As demonstrated in Fig. 1 D, residues 200-258 encompassing the Cdc42 binding CRIB domain of N-WASP constituted the minimal interaction site with EspF, suggesting that EspF could functionally mimic this GTPase. We used an engineered "mini N-WASP" protein possessing the minimal Basic and CRIB regulatory domains linked to the Arp2/3 activating VCA domain to test this hypothesis (Fig. 3 B) (Prehoda et al., 2000) . EspF potently stimulated mini-N-WASP in a dose-dependent manner and the half-maximal activity of mini-N-WASP occurred at an EspF concentration of 11.8 nM as determined by saturation binding experiments (Fig. 3 C) . In total, these data indicate that EspF can relieve N-WASP autoinhibition through a direct binding interaction with the CRIB regulatory domain.
EspF nucleates an active complex composed of SNX9 and N-WASP in vitro
Because both N-WASP and SNX9 bind to residues within the PRR domains of EspF, it was important to determine if their binding sites were mutually exclusive. We found that the SNX9 binding defi cient mutant EspF-D3 induced mini-N-WASPdependent actin polymerization to a similar extent as EspF, suggesting that the RxAPxxP motif did not play a role in N-WASP activation (Fig. 3 E) . Moreover, addition of saturating concentrations of GST-SNX9-SH3 (10 μM) to EspF had a minor affect on N-WASP activation (Fig. 3 E) , suggesting the possibility that EspF can bind SNX9 and N-WASP through two distinct interaction sites.
To directly test the ability of EspF to nucleate a functional SNX9 and N-WASP complex, we fi rst incubated recombinant EspF with GST-SNX9-SH3 immobilized to glutathione-Sepharose beads (Fig. 3 F) . The formation of a stable protein complex between the SH3 domain (34 kD) and EspF (26 kD) was confi rmed by SDS-PAGE analysis (Fig. 3 F) . Next, we added the stable SH3/EspF complex to mini-N-WASP and measured actin polymerization rates (Fig. 3 G) . The SH3/EspF complex directly activated mini-N-WASP-mediated actin assembly kinetics (Fig. 3 G, blue) . In control experiments, actin polymerization kinetics were not increased with SH3 beads alone ( Fig. 3 G, gray), with mutant EspF-D3 that could not form a complex with the SH3 beads ( Fig. 3 G, purple), or with GST control proteins (Fig. 3 G, black) . In total, these data provide strong evidence that EspF coordinates the binding of SNX9 and the activation of N-WASP through two independent binding motifs found within its highly conserved PRR domains (see Fig. 1 
B).
EspF dynamics observed in living cells
SNX9 and N-WASP participate in several membrane traffi cking events and localize to cellular membranes at CCPs and traffi cking organelles (Merrifi eld et al., 2002 (Merrifi eld et al., , 2005 Benesch et al., 2005; Soulet et al., 2005; Yarar et al., 2005) . We used total internal refl ection-fl uorescence microscopy (TIR-FM), a technique that allows fl uorophore-conjugated proteins to be visualized within 100 nm of the cell surface (Steyer and Almers, 2001) , to determine if EspF also localized to the plasma membrane in living cells. EGFP-EspF was transfected into Swiss-3T3 cells stably expressing DsRed-Clathrin light chain-a (Clc-DsRed), a cellular marker of CCPs and the plasma membrane (Merrifi eld et al., 2002) . Several 10-12-min videos were recorded in which EGFP-EspF and Clc-DsRed fl uorescence was simultaneously captured by dual-color TIR-FM (Video 1, available at http://www .jcb.org/cgi/content/full/jcb.200705021/DC1).
Analysis of living cells indicated that EspF was highly dynamic at the plasma membrane and it transiently accumulated into patches at the cell surface (Video 1). Interestingly, EspF partially colocalized with clathrin in still images (Fig. 4 A) and examination of time-resolved videos indicated that 92% (357 of 388 events from 8 cells) of clathrin structures transiently colocalized with EspF ( Fig. 4 B and Video 2, available at http://www.jcb.org/cgi/ content/full/jcb.200705021/DC1). In addition, larger EspF tubules could be found extending near the cell surface (Video 3). Expression of EspF did not affect normal clathrin dynamics, as the lifetime of clathrin at the plasma membrane was nearly identical between untransfected cells (62 ± 4 s, n = 60 events) and EGFPEspF transfected cells (64 ± 5 s, n = 58 events) (Fig. 4 C) . These dynamics were similar to those previously reported for clathrin in Swiss 3T3 cells (Merrifi eld et al., 2002) .
We noticed that the spatial and temporal dynamics of EspF were exquisitely coordinated with clathrin-mediated endocytic events. To quantify these observations, the surface kinetics of EspF was directly compared with clathrin dynamics.
As a reference index, the Clc-DsRed fl uorescence intensity values of 25 clathrin structures were measured from 8 cells expressing EGFP-EspF. We analyzed events in which clathrin appeared at the plasma membrane, was stable for ‫06ف‬ s in the TIR-FM imaging field, and exponentially decayed from the plasma membrane (Fig. 4 D , red trace). These measurements were directly compared with the EGFP-EspF fl uorescence intensities at each CCP. By aligning all 25 EspF traces relative to clathrin membrane departure, it was clear that EspF displayed a tightly (top) . Cell lysates were probed by V5 or GFP immunoblot to show input levels (bottom two panels). (B) A diagram depicting N-WASP ∆EVH1 and mini-N-WASP proteins used in actin polymerization experiments and a Coomassie-stained gel of purifi ed 6×His EspF∆47 (residues 48-206) used in the actin polymerization experiments. (C) Pyrene-actin assembly assay demonstrating EspF activates N-WASP in vitro. The polymerization kinetics of actin alone (red) was not increased by addition of 500 nM EspF (gold). Polymerization curves of Arp2/3 and N-WASP∆EVH1 (light green) compared with these components plus 500 nM EspF (blue) is shown. Unless otherwise stated, all assays contain 2.5 μM pyrene-actin, 40 nM Arp2/3 complex, and 100 nM N-WASP proteins. (D) EspF activates mini-N-WASP in vitro. A pyrene-actin assembly assay showing that EspF activated mini-N-WASP in a dose-dependent manner (blue). The rate of actin polymerization for each EspF concentration was determined at 2 μM G-actin consumption (80%) and plotted against EspF protein concentration (right graph). (E) Pyrene actin assembly assays comparing EspF (100 nM) and mutant EspF-D3 (100 nM) activating mini-N-WASP. Addition of 10 μM GST-SNX9 (SH3) domain to EspF∆47 had a negligible affect on mini-N-WASP activation. (F) Schematic depicting the experimental procedure for Fig. 3 G (left) and an SDS-PAGE of GST (1), GST-SNX9-SH3 (2), GST-SNX9-SH3 in complex with EspF∆47 (3), and GST-SNX9-SH3 control that did not form a complex with mutant EspF-D3 (4). The mobility of the stable SH3/EspF∆47 complex is indicated. Non-specifi c (NS) bands are indicated (*). (G) Mini-N-WASP actin polymerization assay on protein complexes described in Fig. 3 F. coordinated spatiotemporal localization pattern at the plasma membrane. First, EspF was recruited to the plasma membrane at preexisting CCPs (Fig. 4 D, green trace) . The peak EspF fl uorescence signal coincided with the exponential decay of clathrin signal from the plasma membrane (Fig. 4 D, arrow) . Because these clathrin dynamics are indicative of clathrin coatedvesicle movement away from the plasma membrane and vesicle scission (Merrifi eld et al., 2005) , EspF is likely to associate with actively budding membrane domains. Second, EspF remained at the cell surface beyond the time of clathrin departure, suggesting that EspF was associated with the plasma membrane and not in CCPs (Fig. 4 D) . Finally, EspF signal decayed in the TIR-FM image, indicating its retreat from the plasma membrane.
Next, we examined if EspF dynamics at the plasma membrane correlated with the protein interactions defi ned by our in vitro data. The triple-mutant EspF-D3 protein did not interact with SNX9, but maintained N-WASP binding activity ( Fig. 2 F and Fig. 3 E) . Therefore, this mutant was used to determine the potential contributions of SNX9 binding on EspF dynamics. We recorded several TIR-FM videos from cells expressing EGFP-EspF-D3 (Fig. 4 E) and compared its dynamics to wild-type EspF (Fig. 4 F) . EspF-D3 was recruited to 86% (112 of 130 events from 5 cells) of cell surface clathrin structures. Unlike EspF, however, EspF-D3 departed from the plasma membrane coincident with or slightly before clathrin-mediated endocytosis (Fig. 4 F) . The average lifetime of EspF-D3 associated with endocytic sites (12.3 ± 5 s, n = 108 events) was approximately fi vefold shorter than wild-type EspF (68 ± 14.5 s, n = 98 events) (Fig. 4 G) . It was also clear that EspF-D3 did not exhibit the prolonged plasma membrane localization that wild-type EspF displayed after clathrin departure. These data are consistent with the ability of EspF to interact with SNX9 at the plasma membrane ( Fig. 4 H) ; however, additional experimental approaches are necessary to directly establish this link. 
EspF remodels cellular membranes through the activation of SNX9
Using wide-fi eld fl uorescence microscopy, we found that endogenous SNX9 localized to CCPs at the surface of HeLa cells and accumulated in perinuclear regions near the Golgi apparatus (Fig. 5 A) (Lundmark and Carlsson, 2003; Soulet et al., 2005) . Transient transfection of EspF induced a redistribution of SNX9 from CCPs and perinuclear regions to "worm-like" tubular structures found near the cell periphery (Fig. 5 A; Fig. S1 A, available at http://www.jcb.org/cgi/content/full/jcb.200705021/DC1). In these cells SNX9 and EspF colocalized at tubular structures, suggesting that SNX9 redistribution was directly associated with EspF binding (Fig. 5 A and Fig. S1 B) . Consistent with this notion, mutant EspF-D3 had no affect on SNX9 localization. To test these observations in a more controlled cellular environment, we artifi cially increased the SNX9 expression levels by transfecting mCherry-SNX9 into HeLa cells. Exogenous SNX9 had a predominantly perinuclear localization and a small proportion could also be found in cell surface puncta reminiscent of CCPs (Fig. 5 B) . We found that coexpression of EspF with SNX9 induced an array of tubular structures that extended into dense tubular networks (Fig. 5 B) . Similar tubular networks were identifi ed in >90% of EspF and SNX9 cotransfected cells and both proteins colocalized at these sites (Fig. 5, B and C) . As expected, mutant EspF-D3 failed to induce SNX9 tubules indicating that SH3 binding is required for SNX9 localization. Moreover, wild-type EspF did not induce tubules upon cotransfection of SNX9∆BAR, a C-terminal deletion mutant of SNX9 in which the putative membrane deforming BAR domain was removed (Fig. 5, B and C) . These data reveal a novel activity of SNX9 to induce cellular tubulation, a phenomenon that is directly linked to EspF binding.
To determine the nature of the abnormal tubules formed by coexpression of EspF and SNX9, EspF was fi rst immunolocalized by electron microscopy (EM). EspF decorated tubular and vesicular membrane structures but was not found in nuclear areas, inside organelles, or randomly distributed throughout the cytoplasm (Fig. 5 D) . Using thin-section EM we identifi ed a striking array of membrane structures in EspF transfected (Fig.  5 E) but not untransfected cells (Fig. 5 F) . The EspF-induced tubules were abnormally curved and in many cases budding profi les could be observed along both sides of the membrane tubules (Fig. 5 G) . In addition, unusually long ‫5.0ف(‬ μm) cell surface invaginations appeared to be continuous with the plasma membrane (Fig. 5 H) and several membrane projections extended from multivesicular organelles (Fig. 5 I) . A dense negative stain was also observed around the new membrane structures, most likely representing the EspF/SNX9 protein coat. We now propose a model whereby EspF activates SNX9; engagement of the SNX9-SH3 domain by the highly specifi c EspF-ligand motif exposes the C-terminal BAR domain to induce membrane remodeling in eukaryotic cells.
EspF coordinates membrane remodeling
and actin polymerization in cells N-WASP was originally shown to induce cell surface fi lopodia projections during cell migration (Miki et al., 1998) ; however, recent fi ndings indicate that it also regulates membrane traffi cking events including actin-based vesicular transport and endocytosis (Merrifi eld et al., 2002 (Merrifi eld et al., , 2004 Benesch et al., 2005; Innocenti et al., 2005; Yarar et al., 2005) . We did not detect the formation of cell surface fi lopodia in EspF-transfected cells. However, de novo F-actin nucleation occurred near membrane tubules induced by EspF and SNX9 coexpression (Fig. 6 A;  Fig. S2 A, available at http://www.jcb.org/cgi/content/full/jcb .200705021/DC1). EspF activation of SNX9 was prerequisite for these downstream signaling events, as F-actin appeared normal in cells expressing mutant EspF-D3 (Fig. 6 B) . These data suggest that membrane tubulation occurs before actin polymerization in the EspF/SNX9/N-WASP signaling cascade. In support of this conclusion, depolymerization of actin had no affect on the formation of membrane tubules; however F-actin was perturbed at these sites (Fig. S2, C and D) . Moreover, N-WASP redistributed from the cellular cytoplasm to membrane tubules in EspF-transfected cells (Fig. 6 C) but not in cells expressing mutant EspF-D3 (Fig. 6 D) . In total, these data indicate that membrane targeting and subsequent remodeling by EspF is required for its activation of downstream signaling events.
Several additional lines of evidence also suggest that EspF activates N-WASP at membrane sites. Careful examination of the cell surface dynamics of EspF by TIR-FM indicated that a small proportion of EspF puncta ‫)%5ف(‬ formed "comet tails" and seemed to propel the clathrin structure over a very short distance just before clathrin internalization (Fig. 6 E; Video 4, available at http://www.jcb.org/cgi/content/full/jcb.200705021/DC1). This EspF behavior is reminiscent of actin fi lament dynamics observed in Listeria comet tails (Theriot et al., 1992) and the projectile motion of endocytic vesicles at the tips of actin tails (Merrifi eld et al., 1999) . EspF was also found at mobile clathrin structures that moved parallel to the plasma membrane, a phenotype that may occur due to changes in the actin cytoskeletal architecture (Fig. 6 F ; Video 5) . In total, these cellular observations indicate that EspF functions as a bacterial signaling node, integrating the activation of two signaling cascades at membranes of eukaryotic cells (Fig. 6 G) .
Investigation of bacterial delivered EspF in polarized epithelial cells
Next, we sought to determine the potential role of EspF signaling in epithelial models of EPEC infection. Genetic studies have implicated EspF in several pathogenic phenotypes, including the deregulation of the tight-junction ion barrier function in EPEC-infected polarized epithelial cells Dean and Kenny, 2004; Shiffl ett et al., 2005) . We found a dramatic loss of trans-epithelial electrical resistance (TER, a measure of tight junction integrity) in polarized T84 colonic epithelial cells infected with wild-type EPEC that was dependent on the espF gene (Fig. 7 A) ). Interestingly, both plasmid-expressed EPEC espF (pespF) as well as EHEC espFu/tccp (pespFu/tccp) trans-complemented the espF − mutant strain (Fig. 7 A) (Viswanathan et al., 2004) . Similarly, we found that espF − mutant strain expressing the SNX9 bindingdefi cient mutant EspF-D3 (pespF-D3) also induced a loss of TER (Fig. 7 A) . These confounding data suggest that multiple genes in EPEC are responsible for tight junction breakdown and suggest that the complex phenotype cannot be ascribed to EspF function alone.
Next, we wanted to directly test the cytoplasmic role of EspF in polarized epithelial cells. Tight junction breakdown was monitored by the redistribution of occludin from a uniform band outlining the cell junctions in uninfected cells (Fig. 7 B) to a discontinuous beaded pattern in EPEC infected cells (Fig. 7 C) . To directly test the role of EspF in this process, stable cell lines expressing a tandem affi nity protein tag (TAP; protein A and fl ag) fused to the N-terminus of EPEC EspF were created (Fig. 7 D) . As shown in Fig. 7 E, TAP-EspF was expressed in every cell and localized to small puncta near the apical cell surface. SNX9 interaction seemed to be required for this localization as the SH3-binding mutant EspF-D3 was distributed throughout the cytoplasm and accumulated in nuclear regions (Fig. 7 F) . Importantly, MDCK cells expressing either EspF or EspF-D3 formed normal tight junctions (Fig. 7, E and F) , suggesting that EspF activity alone is not suffi cient to break down tight junctions. Next, we biochemically purifi ed EspF from MDCK cells as an unbiased approach to determine protein complexes associated with EspF in a polarized cell type (Fig. 7 G) . TAP-purifi ed EspF or control parental cell lines were separated by SDS-PAGE and Coomassie stain indicated that the major EspF-binding protein had a molecular weight of ‫07ف‬ kD (Fig. 7 G) . This protein was unambiguously identifi ed as canine SNX9 (MW = 71 kD) by tandem mass spectrometry from two independent experiments (see Materials and methods). Thus, SNX9 is the major target of cytoplasmic EspF in polarized epithelial cells.
Finally, we sought to determine if the localization and function of bacterial delivered EspF relies on interaction with SNX9 in polarized cell types. Human CaCo 2 intestinal epithelial cells were infected with wild-type EPEC or the espF − mutant strain. Whereas wild-type EPEC induced SNX9 membrane tubules, this phenotype did not occur in espF − mutant EPECinfected cells (Fig. 7 H) . The wild-type phenotype was rescued by introducing a plasmid encoding the espF allele (pespF ) into the mutant espF − strain (Fig. 7 H) . However, there was no phenotype associated with mutant strains complemented with SNX9 binding-defi cient espF-D3 (pespF-D3) (Fig. 7 H) . Similar results were also found in EPEC-infected HeLa cells (unpublished data). Western blot analysis confi rmed the expression and secretion of the EspF proteins by wild-type and trans-complemented strains (Fig. 7 I) . These data further indicate that the biochemical activities of EspF that we have described in vitro are likely to occur during EPEC pathogenesis of intestinal epithelial cells.
Discussion
In this study we have obtained evidence for a new model of EspF function during bacterial pathogenesis. Our data suggest that EspF physically links membrane-traffi cking proteins to the actin polymerization machinery in host cells. Several lines of evidence support this hypothesis. First, EspF interacts directly with SNX9 through a highly evolved SH3 domain-binding motif that is repeated several times throughout the EspF coding sequence. Second, EspF stimulates N-WASP/Arp2/3 actin polymerization in reconstitution experiments. Third, our live-cell imaging studies revealed that EspF dynamically localized to CCPs. This subcellular localization is similar to those previously described for both SNX9 and N-WASP (Merrifi eld et al., 2004; Benesch et al., 2005; Innocenti et al., 2005; Soulet et al., 2005) . Fourth, EspF induced membrane remodeling through the activation of SNX9, and the actin polymerization profi les at these sites correlated with the ability of EspF to interact with N-WASP in cells. Finally, the EspFdependent redistribution of SNX9 during bacterial infection suggests that the biochemical and cellular activities that we have described are likely to occur during natural EPEC pathogenesis. The major functional unit of EspF is composed of 3-5 highly conserved proline-rich repeat (PRR) domains of ‫74ف‬ amino acids. The purpose of the repeat sequences and how they confer a eukaryotic signaling response is largely unknown. Recently, EspF was shown to bind SNX9 through an SH3 domain interaction; however, the molecular details and the signifi cance of this fi nding were left unexplored (Marches et al., 2006) . We have expanded these initial observations by considering both the biochemical specifi city of this protein-protein interaction and applying this knowledge to cellular models of EspF function. EspF possesses a single RxAPxxP motif at the N-terminal portion of each PRR domain that confers binding selectivity to the SH3 domain of SNX9. This confi guration allows between three and fi ve high affi nity SNX9 bindings sites per EspF molecule. Thus, the PRR domains may provide the bacterial effector a mechanism to increase protein avidity, or more interestingly, a means to amplify the SNX9 signal through oligomerization (Yarar et al., 2007) . Consistent with these biochemical fi ndings, engagement of the SNX9 SH3 domain by EspF induced robust membrane tubulation in cells. We now propose a concerted model for EspF function; direct binding to the SH3 domain of SNX9 transmits a membrane-remodeling signal to the C-terminal BAR domain. Importantly, similar membrane tubules have been observed upon expression of other BAR domain proteins (Peter et al., 2004) , and we found that EspF-induced membrane tubulation did not occur with a BAR domain deletion mutant of SNX9. The potential importance and mechanism of these intramolecular interactions will be clarifi ed as the EspF/SNX9 effector system is analyzed in biophysical detail.
Although we have focused primarily on the mechanisms of SNX9 activation by EspF, we have also discovered that EspF regulates actin cytoskeletal dynamics. In the context of the pyrene-actin assembly assay, the PRR domains in EspF are suffi cient to induce N-WASP/Arp2/3 actin nucleation. EspF binds directly to the CRIB regulatory domain in N-WASP, a phenomenon similar to the reported mechanism of the Rho GTPase Cdc42. Similar fi ndings have been previously reported for the functionally distinct PRR protein EspFu/TccP (Garmendia et al., 2006) , indicating that both EspF and EspFu/TccP may use similar residues to independently activate N-WASP (Fig. 1) . In addition, we have extended these fi ndings by demonstrating that EspF nucleates a trimeric complex composed of SNX9 and N-WASP. This complex may provide EHEC 0157:H7 a potent mechanism for eukaryotic signal amplifi cation and downstream signaling specifi city during bacterial pathogenesis. For example, bacterial pedestals could be modifi ed by EspFu/TccP activation of N-WASP (Campellone et al., 2004) while membrane traffi cking would be regulated by EspF and the SNX9/N-WASP complex. This idea is particularly intriguing in light of studies by Yarar et al. (2007) that demonstrate the importance of SNX9 oligomerization to activate N-WASP during multiple modes of eukaryotic endocytosis.
EspF mimics an endogenous actin/ membrane-signaling module to regulate membrane traffi cking events
Genetic studies have linked EspF activity to a wide range of biological activities, including mitochondrial apoptosis (Crane et al., 2001; Nougayrede and Donnenberg, 2004) , epithelial barrier disruption , apical microvilli effacement , and inhibition of macrophage phagocytosis (Quitard et al., 2006) . We found EspF to be necessary but not suffi cient to regulate epithelial tight junction architecture during bacterial pathogenesis (see Fig. 7 ), suggesting that the EspF phenotypes observed in bacterial genetic studies may result from the concerted actions of several type III effector proteins or additional bacterial signaling mechanisms . Taking an alternative approach to bacterial genetics, we found that purifi ed EspF binds directly to SNX9 in vitro and activates N-WASP in reconstitution assays. These activities could have direct and profound effects on membrane traffi cking and the overall homeostasis of infected intestinal epithelial cells. For example, a recent report suggests that the Aquaporin (AQP) water channels are mislocalized during A/E pathogen infection, and this phenotype requires EspF expression (Guttman et al., 2007) . In addition, EspF promotes the internalization of tight junction proteins in vivo (Guttman et al., 2006) , potentially through a membrane-traffi cking phenotype. These possibilities are consistent with our observed localization of EspF at clathrin structures, as membrane traffi cking is required for epithelial tight junction maintenance and the formation of the apical/basolateral poles (Wells et al., 2006) .
It is intriguing to note that the coordinated activation of SNX9 and N-WASP by EspF may actually represent a pathogenic strategy to mimic a natural host SNX9/N-WASP signaling complex. In earlier studies, our lab found that the Drosophila SNX9 (DSH3PX1) links axonal guidance receptors directly to N-WASP and the actin cytoskeleton (Worby et al., 2001) . In addition, more recent studies suggest that engagement of the T cell antigen receptor (TCR) combined with costimulation of CD28 evoked the formation of a SNX9/WASP complex at endocytic sites of T cells (Badour et al., 2007) . Together, these data establish the importance of an endogenous SNX9 and N-WASP signaling complex to regulate diverse eukaryotic traffi cking events. Importantly, the functional link between these proteins may extend beyond clathrin-mediated endocytosis. Yarar et al. (2007) have described a mechanism in which SNX9 directly activates N-WASP for the purpose of regulating dorsal membrane ruffl es, clathrin-independent fl uid-phase endocytosis, and uptake of GPI-anchored proteins. Thus, our data suggest for the fi rst time that EspF hijacks an endogenous SNX9/N-WASP signaling complex involved in multiple host cellular regulatory pathways.
Materials and methods
Plasmids
The espf gene from EHEC O157:H7 (GenBank accession no.#AP002566) and the EPEC E2348/69 espf were PCR cloned in-frame into pEGFP-C2 (CLONTECH Laboratories, Inc.). The espfu/tccp gene was cloned from a clinical isolate of EHEC 0157:H7 and has the sequence identical to GI: 15831969. The yeast two-hybrid clone of mouse SNX9 (NM_025664) residues 1-111, as well as full-length human SNX9, N-WASP, Grb2, NckI, and Nck2 were Topo cloned into pcDNA3.1-V5-His (Invitrogen). To produce mCherry-SNX9, the EGFP from pEGFP-C1 was replaced with mCherry by PCR subcloning. For bacterial expression, 47 amino acid N-terminal deletions (∆N47) of EspF were PCR subcloned into pGEX-4T1 (GST-tag) (GE Healthcare) or pet30A (6xHis tag) (Novagen). EspF-D3 was generated with Multi-site QuikChange Site-Directed Mutagenesis (Stratagene) following the manufacturer's instructions. For bacterial complementation, the EPEC espf or mutant espf-D3 was Topo cloned into pTrcHis2 with a c-myc epitope tag (Invitrogen). GST and His-tagged mini-N-WASP were obtained from Wendall Lim (University of California, San Francisco, San Francisco, CA; Prehoda et al., 2000) . All constructs were verifi ed by DNA sequencing.
Yeast two-hybrid
The yeast expression vector pLexA encoded a gene with N-terminal LexA binding domain and residues 1-248 of EHEC EspF. 250 μg of a d 9.5 and 10.5 mouse embryo library in VP16 were screened using the yeast two-hybrid system as previously described (Alto et al., 2006) .
Cell culture, transfection, and wide-fi eld fl uorescence microscopy Cell culture, transfections, and wide-fi eld fl uorescence microscopy was performed as previously described (Alto et al., 2006) . Images were acquired on a microscope (Axiovert; Carl Zeiss Microimaging, Inc.) using a digital camera (MicroMax; Roper-Princeton Instruments) controlled by MetaFluor software (Universal Imaging, Corp.) . Optical fi lters were obtained from Chroma Technologies and 40 or 63× objectives were used for image acquisition.
Antibodies
Concentrations of anti-GFP polyclonal and monoclonal (CLONTECH Laboratories, Inc.), anti-His (QIAGEN), anti-GST, anti-fl ag M2, anti-fl ag polyclonal (Sigma-Aldrich), anti-HA (Covance), and anti-occludin (Zymed Laboratories) were used for immunoprecipitation, immunocytochemistry, and immunoblotting as recommended by the manufacturer. Rabbit polyclonal SNX9 antibody was used at 1:200 (Soulet et al., 2005) . Rabbit polyclonal EspF was used at 1:10,000 ). Antitubulin antibody was used at 1:200 (Sigma-Aldrich), and Latrunculin-A at 1 μM (Calbiochem).
Recombinant protein production and GST pull-down assays Recombinant 6×His EspF∆47, mini-N-WASP (from Wendall Lim), N-WASP ∆EVH1 (from Jack Taunton; University of California, San Francisco, San Francisco, CA) and SNX9 were produced in BL-21/DE3 E. coli strain following standard methods. Cells were lysed in either His buffer (50 mM Tris, pH 7.4, 300 mM NaCl, 10 mM imidazole, and 0.5% Triton-X 100) or GST buffer (phosphate-buffered saline) supplemented with protease cocktail (Roche). Proteins were purifi ed with Nickel agarose (QIAGEN) or glutathione-Sepharose (GE Healthcare) following the manufacturer's instructions. Proteins were dialyzed overnight in 2 l of lysis buffer at 4°C. Glycerol was added to 30% and aliquots were stored at −80°C. For GST pull-down assays, 10 μg of recombinant GST proteins immobilized to glutathione-Sepharose was incubated with 50 μl of [
35 S]-methionine (GE Healthcare) produced with TNT reaction (Promega) for 4 h at 4°C. Proteins were separated by SDS-PAGE, dried, and exposed by autoradiography.
Peptide array and SNX9 overlay
Immobilized peptides were synthesized on cellulose paper using a Multipep Autospot synthesis robot following the manufacturer's directions (Intavis AG). Membranes were blocked in 5% milk in TBS-Tween. 50 μl of [
35 S]-methionine SNX9 produced by TNT (Promega) was added to 5 ml of block solution and overlayed onto peptide membranes for 4 h at room temperature. Membranes were washed 3× 10 min in TBS-T and exposed by autoradiography.
Fluorescence polarization FITC-labeled peptides (Cell Essentials) used for fl uorescence polarization include EspF residues 69-86 (FITC-A T S F T P S R P A P P P T S G Q A ) or control peptide (FITC-Q I A K R R R L S S L R A ). Peptides (5 nM) were suspended to working dilutions in PBS with 5 mg/ml BSA. Increasing concentrations of purifi ed GST-SNX9-SH3 or control GST proteins were mixed with peptides in 100 μl and incubated at room temperature for 10 min. Fluorescence polarization (FP) was measured on a GENios Pro (TECAN) fi tted with FP excitation and emission fi lters, 485/535 nm. Polarization values (mP) were determined at equilibrium and normalized to the highest value of saturation. Saturation binding curve was generated with PRISM software (Graph Pad) and dissociation constants (K D ) were calculated from the nonlinear regression curve from averages of three independent experiments.
Phage display
A library of random dodecapeptides fused to the N terminus of the M13 gene-8 major coat protein was constructed and cycled through rounds of binding selections with the bacterially expressed SH3 domain immobilized on 96-well Maxisorp immunoplates (NUNC), as described previously (Sidhu et al., 2000; Laura et al., 2002) . After four rounds of selection, individual phage were isolated and analyzed in a phage ELISA. Phage that bound to the SH3 domain was subjected to DNA sequence analysis.
Actin polymerization assays 1:1 mix of pyrene actin ‫%04ف(‬ labeled, fi nal is ‫%02ف‬ labeled) to cold G-actin (Cytoskeleton, Inc.) were mixed in G-buffer (5 mM Tris, pH 8.0, 0.2 mM CaCl 2 , 0.2 mM ATP, and 1 mM DTT) and centrifuged at 100,000 g for 2 h. A fi nal of 2.5 μM pyrene actin mix was added to 270 μl of Arp2/3 buffer (20 mM Tris, pH 7.5, 25 mM KCl, 1 mM MgCl 2 , 0.1 mM ATP, and 1 mM ATP). 40 nm bovine Arp2/3 (a gift from Tom Pollard; Yale University, New Haven, CT) and 100 nM mini-N-WASP or N-WASP ∆EVH1 was mixed with various concentrations of GST, GST-EspF, or SNX9 constructs in 30 μl of 10× actin polymerization buffer (100 mM Tris, pH 7.5, 500 mM KCl, 20 mM MgCl 2 , and 10 mM ATP). 270 μl pyrene actin (2.5 μM) was mixed with 30 μl mini-N-WASP-Arp2/3 and actin-assembly kinetics was monitored by pyrene fl uorescence over a 10-20-min time interval. Peak fl uorescence values were normalized to 2.4 μM actin consumption and graphed with PRISM Software.
Total internal refl ection fl uorescence microscopy (TIR-FM)
TIR-FM imaging procedures and microscopic manipulations were conducted as previously reported . Swiss 3T3 cells stably expressing clathrin-light chain DsRed (Merrifi eld et al., 2002) were grown to 70% confl uency in a 100-mm tissue culture dish in DME + 10% fetal calf serum and transfected with 20 μg EGFP-EspF or EGFP-EspF-D3 DNA using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. Cells were allowed to recover in fresh medium for 2 h, replated onto 22 × 22-mm, no. 1.5 glass coverslips (Corning; n = 1.523), and fi lmed the following morning.
Total internal refl ection fl uorescence (TIRF) microscopy was performed using an inverted microscope (TE2000U; Nikon) custom-modifi ed to allow for through-the-objective multispectral total-internal refl ection fl uorescence microscopy using a 100×, 1.45 NA objective (Nikon), as previously described . TIRF images were taken for 10 min at 2-3-s intervals, with a 100-300-ms exposure time, depending on the intensity of the signal.
Image analysis
Low expressing EGFP-EspF or EGFP-EspF-D3 cells stably expressing ClcDsRed were chosen for ‫21-8ف‬ min time-lapse movies. Stacks of red (ClcDsRed) and green (GFP-EspF) images were de-interleaved into separate stacks. Clc-DsRed stacks were analyzed for candidate clathrin structures that were stable for 30 s before disappearance and seemed likely to represent single CCPs. Clathrin structures were excluded similar to the criteria described previously (Merrifi eld et al., 2002) . We marked the position of each Clc-DsRed candidate with a ‫-2-1ف‬μm diameter circle and observed GFP-EspF dynamics at these sites. This procedure yielded the coordinates of the CCS in both the red and green channels so that red and green regions precisely centered on the CCS could be excised and stored as ministacks for analysis. All time and fl uorescence intensity measurements were based on these criteria. Image analysis was done with Metamorph (Universal Imaging Corp), Excel, and graphed using PRISM (Graph Pad).
To measure 25 CCPs, we fi rst chose 25 candidate CCPs from 8 different cells. Each CCP appeared during the 10-min video series was stable for at least 30 s, disappeared from the evanescent fi eld, and did not reappear for the remainder of the video series. The peak fl uorescence intensity measurements were collected for each individual EspF and clathrin image and averaged background values were subtracted. Clathrin results were normalized to the mean fl uorescence during the 21 s (7 frames) before the peak clathrin fl uorescence (Merrifi eld et al., 2002) . The time of clathrin departure (time 0) was defi ned as the last frame in which the normalized fl uorescence value was within 90% of peak fl uorescence and the signal reached <5% over the following 45 s of imaging. Each clathrin event (n = 25) was aligned to the time of departure and averaged. For EspF, the results of each event were normalized to the mean of three contiguous intensity values, including the peak value, then aligned to the time of clathrin departure and fi nally averaged (Merrifi eld et al., 2002) . Kymograph analysis was performed using MetaMorph software.
EPEC infection experiments
T84 colonic epithelial cells were cultured and TER experiments were performed as described previously . EPEC and espF − mutant strains (McNamara and Donnenberg, 1998) were complemented with plasmid EspF subcloned into pTrcHis2 (Invitrogen). Plasmid EspF was expressed in EPEC by incubation with 100 μM IPTG for 3 h before EPEC infections. T84 cells were infected with an MOI of 100 for the indicated time points. CaCo 2 experiments were performed by infecting cells with EPEC or the indicated mutants for 4 h before fi xation and immunofl uorescence processing.
MDCK stable cell lines and mass spectrometry TAP-tagged EspF or mutant EspF-D3 were subcloned into pCDNA4T/O and MDCK stable cell lines were generated following the manufacturer's instructions (Invitrogen). Clonal lines expressing TAP-EspF or TAP-EspF-D3 were selected with 500 μg/ml zeocin and confi rmed by Western blot and immunofl uorescence microscopy. Purifi cation of TAP-EspF was performed as follows: MDCK cells were lysed in 50 mM Hepes, pH 7.5, 150 mM NaCl, 5% glycerol, 0.5% TX-100, 1.5 mM MgCl 2 , and 1 mM EGTA and incubated with anti-fl ag M2 beads for 2 h. The beads were washed 3× 10 min with lysis buffer and eluted with LDS-PAGE buffer (Invitrogen). Immunocomplexes were run down SDS-PAGE and gels were stained with Coomassie. Proteins were in-gel digested and analyzed with nano liquid chromatography tandem mass spectrometry. Acquired data was searched with Inspect against a dog database (National Center for Biotechnology Information, Canis familiaris fasta protein database). Identifi ed peptides were manually verifi ed to be canine SNX9: aa 218-237, S A A P Y F K D S E S A E A G-G A Q R ; aa 313-327, S Y I E Y Q L T P T N T N R ; aa 346-359, F G S A I P I P S L P D K ; aa 515-529, T Y E E I A G L V A E Q P K ; aa 543-557, K.G F L G C F P D I I G A H K .G; and aa 605-613, IYDYNSVIR. Fig. S1 shows membrane tubule formation induced by EspF, and colocalization of endogenous SNX9 at these sites (Fig. S1, A and B) . Fig. S2 demonstrates that actin is polymerized de novo at sites of EspF/SNX9 membrane tubules. Video 1 shows dynamics of EGFP-EspF and Clc-DsRed in living Swiss 3T3 cells captured by TIR-FM. Video 2 shows EspF and clathrin dynamics at a single CCP. Video 3 shows a dynamic membrane tubule induced by EspF expressing at the cell surface. Video 4 demonstrates a "rocketing" clathrin structures seemingly being propelled by EspF. Video 5 demonstrates a splitting clathrin structures with EspF localizing to the center of this event.
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